Literature DB >> 9089388

Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin.

F Fukai1, S Hasebe, M Ueki, M Mutoh, C Ohgi, H Takahashi, K Takeda, T Katayama.   

Abstract

We recently found that heparin-binding domain 2 (Hep 2) of fibronectin (FN) exhibits cryptic anti-adhesive activity. In order to locate the anti-adhesive site, a number of synthetic peptides which represents the primary structure of the Hep 2 domain were characterized as to their ability to decrease the adhesion of A375SM melanoma cells to FN substrate. Only one peptide (T-E-A-T-I-T-G-L-E-P-G-T-E-Y-T-I-Y-V-I-A-L, residues 1835-1855) (peptide III14-2), which is situated between the previously identified adhesive sites, FN-C/H-I and II, decreased the cell adhesion to FN. Assaying of the anti-adhesive activities of sub-peptides showed that the hydrophobic moiety of peptide III14-2 (underlined sequence) seems to be indispensable for the anti-adhesive activity. These results suggest that anti-adhesive activity is closely associated with the sequence, Y-T-I-V-I-A-L, that is usually buried within the Hep 2 domain structure because of its hydrophobic nature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089388

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Eukaryotic translation elongation factor 1A induces anoikis by triggering cell detachment.

Authors:  Keisuke Itagaki; Toshihiko Naito; Ryota Iwakiri; Makoto Haga; Shougo Miura; Yohei Saito; Toshiyuki Owaki; Sadahiro Kamiya; Takuya Iyoda; Hirofumi Yajima; Shintaro Iwashita; Shin-ichiro Ejiri; Fumio Fukai
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

Review 2.  Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.

Authors:  Kasturee Chakraborty; Archana Tripathi; Sukumar Mishra; Argha Mario Mallick; Rituparna Sinha Roy
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

3.  VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression.

Authors:  Rika Tanaka; Toshiyuki Owaki; Sadahiro Kamiya; Takuya Matsunaga; Kazuya Shimoda; Hiroaki Kodama; Ryo Hayashi; Takashi Abe; Yosei P Harada; Motoyuki Shimonaka; Hirofumi Yajima; Hiroshi Terada; Fumio Fukai
Journal:  J Biol Chem       Date:  2009-05-21       Impact factor: 5.157

4.  Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.

Authors:  Takuya Iyoda; Fumio Fukai
Journal:  Int J Cell Biol       Date:  2011-12-19

Review 5.  Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.

Authors:  Motomichi Fujita; Manabu Sasada; Takuya Iyoda; Fumio Fukai
Journal:  Molecules       Date:  2020-07-16       Impact factor: 4.411

6.  Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.

Authors:  Motomichi Fujita; Yuka Ito-Fujita; Takuya Iyoda; Manabu Sasada; Yuko Okada; Kazuma Ishibashi; Takuro Osawa; Hiroaki Kodama; Fumio Fukai; Hideo Suzuki
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

Review 7.  Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.

Authors:  Takuya Iyoda; Motomichi Fujita; Fumio Fukai
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

Review 8.  The Functional Role of Extracellular Matrix Proteins in Cancer.

Authors:  Nadezhda V Popova; Manfred Jücker
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

9.  Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim.

Authors:  Takuya Iyoda; Yumi Nagamine; Yoshitomi Nakane; Yuya Tokita; Shougo Akari; Kazuki Otsuka; Motomichi Fujita; Keisuke Itagaki; You-Ichi Takizawa; Hiroaki Orita; Toshiyuki Owaki; Jyunichi Taira; Ryo Hayashi; Hiroaki Kodama; Fumio Fukai
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.